Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
750
Frequently Asked Questions
What is Market Cap of Roivant Sciences Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Roivant Sciences Ltd market cap is $11.04B.
What is the 52-week high for Roivant Sciences Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Roivant Sciences Ltd 52 week high is $16.19 as of October 05, 2025.
What is the 52-week low for Roivant Sciences Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Roivant Sciences Ltd 52 week low is $8.73 as of October 05, 2025.
What is Roivant Sciences Ltd stock price today?
Roivant Sciences Ltd stock price today is $16.17.
What was Roivant Sciences Ltd stock price yesterday?
Roivant Sciences Ltd stock price yesterday was $15.98.
What is the PE ratio of Roivant Sciences Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Roivant Sciences Ltd’s P/E ratio is -23.14.
What is the Price-to-Book ratio of Roivant Sciences Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Roivant Sciences Ltd P/B ratio is 2.5386.
What is the 50-day moving average of Roivant Sciences Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Roivant Sciences Ltd 50-day moving average is $12.96.